ATE308540T1 - Antithrombosemittel - Google Patents

Antithrombosemittel

Info

Publication number
ATE308540T1
ATE308540T1 AT01961622T AT01961622T ATE308540T1 AT E308540 T1 ATE308540 T1 AT E308540T1 AT 01961622 T AT01961622 T AT 01961622T AT 01961622 T AT01961622 T AT 01961622T AT E308540 T1 ATE308540 T1 AT E308540T1
Authority
AT
Austria
Prior art keywords
antithrombotic agents
prodrug
compound
inhibitor
factor
Prior art date
Application number
AT01961622T
Other languages
English (en)
Inventor
Douglas Wade Beight
John Joseph Masters
Jason Scott Sawyer
Robert Theodore Shuman
Michael Robert Wiley
Ying Kwong Yee
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE308540T1 publication Critical patent/ATE308540T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01961622T 2000-08-17 2001-08-06 Antithrombosemittel ATE308540T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22592600P 2000-08-17 2000-08-17
PCT/US2001/021130 WO2002014308A1 (en) 2000-08-17 2001-08-06 Antithrombotic agents

Publications (1)

Publication Number Publication Date
ATE308540T1 true ATE308540T1 (de) 2005-11-15

Family

ID=22846837

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01961622T ATE308540T1 (de) 2000-08-17 2001-08-06 Antithrombosemittel

Country Status (7)

Country Link
US (1) US6924296B2 (de)
EP (1) EP1311501B1 (de)
AT (1) ATE308540T1 (de)
AU (1) AU2001282871A1 (de)
DE (1) DE60114640T2 (de)
ES (1) ES2248380T3 (de)
WO (1) WO2002014308A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001297648A1 (en) 2000-11-28 2002-08-28 Eli Lilly And Company Substituted carboxamides as inhibitors of factor xa
US20030050648A1 (en) * 2001-09-11 2003-03-13 Spiration, Inc. Removable lung reduction devices, systems, and methods
EP1456175A1 (de) 2001-12-07 2004-09-15 Eli Lilly And Company Substituierte heterozyklische karboxamide mit antithrombotischer aktivität
PL377633A1 (pl) * 2003-04-03 2006-02-06 Merck Patent Gmbh Związki karbonylowe
US20050119266A1 (en) * 2003-10-01 2005-06-02 Yan Shi Pyrrolidine and piperidine derivatives as factor Xa inhibitors
US7622496B2 (en) * 2005-12-23 2009-11-24 Zealand Pharma A/S Modified lysine-mimetic compounds
CA2637209A1 (en) * 2006-01-17 2007-07-26 Zogenix, Inc. Single-dose needle-free administration of antithrombotic medications
WO2008057775A2 (en) 2006-10-27 2008-05-15 Bristol-Myers Squibb Company Heterocyclic amide compounds useful as kinase inhibitors
CN101239937B (zh) * 2007-02-07 2010-05-19 上海雅本化学有限公司 一种光学活性r-(-)-1-苄氧羰基-3-氨基吡咯烷及其盐酸盐的制备方法
EP1975165A1 (de) * 2007-03-27 2008-10-01 Boehringer Ingelheim Pharma GmbH & Co. KG Substituierte Pyrrolidinamide, deren Herstellung und deren Verwendung als Arzneimittel
RU2643336C1 (ru) * 2016-10-03 2018-01-31 Общество с Ограниченной Ответственностью "Компания "ЭЛТА" СРЕДСТВО, ПРОЯВЛЯЮЩЕЕ АНТИТРОМБОТИЧЕСКИЙ ЭФФЕКТ ПОСРЕДСТВОМ БЛОКИРОВАНИЯ РЕЦЕПТОРОВ ТРОМБОЦИТОВ ГП IIb-IIIa (ВАРИАНТЫ)
DK3993876T3 (en) 2019-07-01 2024-12-02 Tonix Pharma Ltd Anti-cd154 antibodies and uses thereof
AU2022205313A1 (en) 2021-01-06 2023-07-20 Tonix Pharma Limited Methods of inducing immune tolerance with modified anti-cd154 antibodies
WO2025248134A1 (en) 2024-05-31 2025-12-04 Tonix Pharma Limited Treatment methods comprising administration of modified cd154 antibodies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1014962A4 (de) 1997-06-26 2007-06-27 Lilly Co Eli Antitrombotische mitteln
CA2294240A1 (en) 1997-06-26 1999-01-07 Trelia Joyce Craft Antithrombotic agents
IL133625A0 (en) 1997-06-26 2001-04-30 Lilly Co Eli Antithrombotic agents
JP2002506462A (ja) 1997-06-26 2002-02-26 イーライ・リリー・アンド・カンパニー 抗血栓物質
ATE240316T1 (de) 1998-12-23 2003-05-15 Lilly Co Eli Heteroaromatische amide als inhibitoren von faktor xa
CA2361149A1 (en) * 1998-12-23 2000-07-06 Eli Lilly And Company Aromatic amides
EP1140881B1 (de) 1998-12-23 2006-05-17 Eli Lilly And Company Antithrombotische amide
ATE261941T1 (de) 1998-12-24 2004-04-15 Lilly Co Eli Heterocyclische amide als inhibitoren von faktor xa
ATE374765T1 (de) 2000-07-27 2007-10-15 Lilly Co Eli Substituierte heterocyclische amide

Also Published As

Publication number Publication date
ES2248380T3 (es) 2006-03-16
DE60114640D1 (en) 2005-12-08
DE60114640T2 (de) 2006-07-20
AU2001282871A1 (en) 2002-02-25
EP1311501B1 (de) 2005-11-02
US20040010017A1 (en) 2004-01-15
WO2002014308A1 (en) 2002-02-21
EP1311501A1 (de) 2003-05-21
US6924296B2 (en) 2005-08-02

Similar Documents

Publication Publication Date Title
ATE306261T1 (de) Antithrombosemittel
ATE297203T1 (de) Antithrombotische mitteln
DE69931393D1 (de) Antithrombotische amide
ATE272633T1 (de) Aromatische amiden
AU2001280438A1 (en) Substituted heterocyclic amides
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
CY1107634T1 (el) Φαρμακευτικη συνθεση
MXPA03005464A (es) Agentes antivirales.
ES2196917T3 (es) Amidas heteroaromaticas como inhibidores del factor xa`.
SE0302760D0 (sv) New compounds
DE602005016297D1 (de) Antithrombotische diamide
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
DE602005019316D1 (en) Aromatische etherderivate als thrombin-hemmer
AU2364000A (en) Heterocyclic amides as inhibitors of factor xa
NO20040881L (no) Orale antidiabetes midler.
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
DE60114640D1 (en) Antithrombosemittel
WO2005049604A3 (en) Antithrombotic aromatic ethers
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
GB0212410D0 (en) Organic compounds
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
SE0102057D0 (sv) New Salts I
ATE348800T1 (de) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
SE0102058D0 (sv) New Salts II
ATE382607T1 (de) Antitrombotische aether

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties